Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

fMRI and Neurophysiological Study Protocol on Cannabinoids in Multiple Sclerosis

NCT00202423 is registered in ClinicalTrials.gov with S. Andrea Hospital as lead sponsor.

NCT NCT00202423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00202423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
fMRI and Neurophysiological Study Protocol on Cannabinoids in Multiple Sclerosis
Lead sponsor
S. Andrea Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
July 31, 2005
Completion date
Not reported
Enrollment
20
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis